BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32996568)

  • 1. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
    Saeed SM; Naffouje S; Mehta R; Hoffe SE; Fontaine JP; Lauwers GY; Shah P; Frakes J; Pimiento JM
    Dis Esophagus; 2021 Aug; 34(8):. PubMed ID: 32996568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients With Esophageal Squamous Cell Carcinoma.
    Wang BY; Lin CH; Wu SC; Chen HS
    Ann Surg; 2023 Jan; 277(1):e53-e60. PubMed ID: 34117148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort.
    Zhang R; Zou J; Li P; Li Q; Qiao Y; Han J; Huang K; Ruan P; Lin H; Song Q; Fu Z
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31175353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.
    Oshikiri T; Takiguchi G; Miura S; Goto H; Otsubo D; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Nov; 26(12):4053-4061. PubMed ID: 31313045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term outcomes of thoracoscopic esophagectomy in the prone position for esophageal squamous cell carcinoma in patients with obstructive ventilatory disorder: a propensity score-matched study.
    Goto H; Oshikiri T; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Surg Endosc; 2022 Dec; 36(12):8834-8842. PubMed ID: 35546208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
    Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
    BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.
    Yang Y; Zhang X; Li B; Hua R; Yang Y; He Y; Ye B; Guo X; Sun Y; Li Z
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31608939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
    Pan L; Zhang Y; Gao Y; Qiu J
    Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.
    Sun Y; Wang J; Li Y; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Zhang X
    Future Oncol; 2019 Jan; 15(2):121-132. PubMed ID: 30232909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.
    Yamamoto M; Shimokawa M; Yoshida D; Yamaguchi S; Ohta M; Egashira A; Ikebe M; Morita M; Toh Y
    J Cancer Res Clin Oncol; 2020 May; 146(5):1351-1360. PubMed ID: 32185488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score-matched comparison between open and minimal invasive hybrid esophagectomy for esophageal adenocarcinoma.
    Hölscher AH; DeMeester TR; Schmidt H; Berlth F; Bollschweiler E
    Langenbecks Arch Surg; 2020 Jun; 405(4):521-532. PubMed ID: 32388717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-Matched Analysis Comparing Survival After Hybrid Thoracoscopic-Laparotomy Esophagectomy and Complete Thoracoscopic-Laparoscopic Esophagectomy.
    Li KK; Wang YJ; Liu XH; Wang RW; Jiang YG; Guo W
    World J Surg; 2019 Mar; 43(3):853-861. PubMed ID: 30386913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
    Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
    Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Li T; Fu X; Xiao L; Su L; Dai Y; Yao Q; Li J
    Medicine (Baltimore); 2019 Oct; 98(42):e17637. PubMed ID: 31626150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
    Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
    BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.